Results 1 to 20 of 31
Page 1 of 2  Next >
TypeTitleAuthor(s)YearViews
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations.Sawai, H; Nishida, N; Mbarek, H; Matsuda, K; Mawatari, Y; Yamaoka, M; Hige, S; Kang, JH; Abe, K; Mochida, S; Watanabe, M; Kurosaki, M; Asahina, Y; Izumi, N; Honda, M; Kaneko, S; Tanaka, E; Matsuura, K; Itoh, Y; Mita, E; Korenaga, M; Hno, K; Murawaki, Y; Hiasa, Y; Ide, T; Ito, K; Sugiyama, M; Ahn, SH; Han, KH; Park, JY; Yuen, RMF; Nakamura, Y; Tanaka, Y; Mizokami, M; Mizokami, M; Tokunaga, K201284
 
Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infectionYuen, MF; Wong, DKH; Lee, CK; Tanaka, Y; Allain, JP; Fung, J; Leung, J; Lin, CK; Sugiyama, M; Sugauchi, F; Mizokami, M; Lai, CL2011380
 
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulationMukaide, M; Tanaka, Y; ShinI, T; Yuen, MF; Kurbanov, F; Yokosuka, O; Sata, M; Karino, Y; Yamada, G; Sakaguchi, K; Orito, E; Inoue, M; Baqai, S; Lai, CL; Mizokami, M2010182
 
The duration of lamivudine therapy for chronic hepatitis b: Cessation vs. continuation of treatment after HBeAg seroconversionFung, J; Lai, CL; Tanaka, Y; Mizokami, M; Yuen, J; Wong, DKH; Yuen, MF200967
 
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis BYuen, MF; Tanaka, Y; Fong, DYT; Fung, J; Wong, DKH; Yuen, JCH; But, DYK; Chan, AOO; Wong, BCY; Mizokami, M; Lai, CL2009449
 
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis BYuen, RMF; Tanaka, Y; Fong, DYT; Fung, JYY; Wong, DKH; Yuen, JCH; But, D; Chan, AOO; Wong, BCY; Mizokami, M; Lai, CL2008146
 
Three-year assessment of entecavir resistance in chronic hepatitis B patients and the mechanism of viral breakthrough by the resistance substitutionsTanaka, Y; Mukaide, M; Yuen, RMF; Shin, IT; Orito, E; Kurbanov, F; Fukai, K; Yokosuka, O; Sata, M; Ide, T; Karino, Y; Yamada, G; Sakaguchi, K; Inoue, M; Gish, RG; Lai, CL; Mizokami, M2008185
 
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levelsYuen, MF; Tanaka, Y; Shinkai, N; Poon, RT; But, DYK; Fong, DYT; Fung, J; Wong, DKH; Yuen, JCH; Mizokami, M; Lai, CL2008401
 
Profiles of HBV DNA, ALT and HBeAG status after stopping lamivudine in patients with HBeAg seroconversionFung, JYY; Lai, CL; Tanaka, Y; Mizokami, M; Yuen, JCH; Wong, DKH; Yuen, RMF200782
 
Role of HBV genotypes, core promoter/precore mutations and HBV DNA levels on hepatocarcinogenesisYuen, RMF; Tanaka, Y; Shinkai, N; Poon, RTP; Fung, JYY; Wong, DKH; Yuen, JCH; Mizokami, M; Lai, CL2007140
 
Role of HBV genotypes, core promoter/precore mutations and HBV DNA levels on hepatocarcinogenesisYuen, RMF; Tanaka, Y; Shinkai, N; Poon, RTP; Fung, JYY; Wong, DKH; Yuen, JCH; Mizokami, M; Lai, CL2007107
 
Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian populationFung, J; Lai, CL; Yuen, JCH; Wong, DKH; Tanaka, Y; Mizokami, M; Yuen, MF2007102
 
Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversionFung, JYY; Lai, CL; Tanaka, Y; Mizokami, M; Yuen, JCH; Wong, DKH; Yuen, RMF2007114
 
Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infectionWong, DKH; Tanaka, Y; Lai, CL; Mizokami, M; Fung, J; Yuen, MF200778
 
Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinomaTanaka, Y; Mukaide, M; Orito, E; Yuen, MF; Ito, K; Kurbanov, F; Sugauchi, F; Asahina, Y; Izumi, N; Kato, M; Lai, CL; Ueda, R; Mizokami, M2006131
 
A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and COrito, E; Fujiwara, K; Tanaka, Y; Yuen, MF; Lai, CL; Kato, T; Sugauchi, F; Kusakabe, A; Sata, M; Okanoue, T; Niitsuma, H; Sakugawa, H; Hasegawa, I; Mizokami, M2006102
 
Detection of hepatitis B virus core-related antigens as a marker for the monitoring of viral activity during nucleoside analogue therapyWong, DKH; Tanaka, Y; Lai, CL; Mizokami, M; Yuen, RMF200669
 
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortalityTanaka, Y; Kurbanov, F; Mano, S; Orito, E; Vargas, V; Esteban, JI; Yuen, M; Lai, C; Kramvis, A; Kew, MC; Smuts, HE; Netesov, SV; Alter, HJ; Mizokami, M2006119
 
Detection of hepatitis B virus core-related antigens as a marker for the monitoring of viral activity during nucleoside analogue therapyWong, DKH; Tanaka, Y; Lai, CL; Mizokami, M; Yuen, RMF200680
 
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortalityTanaka, Y; Kurbanov, F; Vargas, V; Esteban, J; Yuen, RMF; Lai, CL; Kramvis, A; Kew, M; Alter, HJ; Mizokami, M200579
 
Page 1 of 2  Next >
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download